Skip to main content
. 2024 Dec 12;16(12):1589. doi: 10.3390/pharmaceutics16121589

Figure 4.

Figure 4

Nebulization performance, including the (A) nebulization time to “dryness” (min), (B) mass output (%), and (C) output rate (mg/min) of TRES-NLC formulation F14. Data are mean ± SD, n = 3.